SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, the company announced. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. SS Innovations said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system. This includes 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also stated that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. The full press release is available at https://ibn.fm/XWdRe.
The award highlights the growing importance of surgical robotics in making advanced medical procedures more accessible. The SSi Mantra system’s cost efficiency and user-friendly design could help lower the barriers to robotic surgery adoption in hospitals worldwide. With regulatory approvals in 14 countries and a growing number of procedures, SS Innovations is positioning itself as a key player in the global surgical robotics market.
SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available on the Company’s website at ssinnovations.com.
The award comes at a time when the surgical robotics industry is rapidly evolving, with increasing demand for systems that can improve patient outcomes and reduce healthcare costs. The recognition of SS Innovations underscores the potential of its technology to address these needs. However, as with any forward-looking statements, investors are advised to consider the risks outlined in the Company’s filings with the SEC, including those discussed under the heading “Risk Factors” in its most recent Annual Report on Form 10-K and subsequent filings. The full disclaimer is available at http://IBN.fm/Disclaimer.
